←
Kenneth Jacobson40 posts
Kenneth Jacobson avatar

Kenneth Jacobson

@KAJacobson

Dr. Jacobson is Chief of the Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases

◷ Joined May 2009▧ 1 Photos and videos
Stuart Schreiber avatar
⟳ Kenneth Jacobson retweeted
Stuart Schreiber@SchreiberStuart·Nov 2

Throughout his career, Jon Clardy helped shape the field of natural products. His record of discovering the most influential naturally occurring small molecules is extraordinary and unmatched. He was a humble man, and his kindness and warmth will be deeply missed

Jon Clardy: 1943-2026 One of the most impactful, creative, and (quietly) irreverent practitioners of chemical biology. Transformed how we think about nature's chemicals: their structures, their role in biology. Loved him -- he had tremendous influence on my thinking.

Post attachment
Astrocyte Pharmaceuticals avatar
⟳ Kenneth Jacobson retweeted
Astrocyte Pharmaceuticals@AstrocytePharma·Sep 12

Great new research on A3R agonism in brain homeostasis, reinforcing its role as a brain stress sensor that translates extracellular adenosine changes into adaptive glial responses, with implications for protecting the brain during stress and injury! science.org/doi/10.1126/scia…

Communications Biology avatar
⟳ Kenneth Jacobson retweeted
Communications Biology@CommsBio·9 Dec 2025

UDP-glucose and MRS2905 agonist-bound states of the purinergic P2Y14 receptor: Communications Biology, Published online: 21 November 2025; doi:10.1038/s42003-025-09174-6The authors cracked P2Y14’s “sweet tooth”: structures bound to UDP-glucose and… nature.com/articles/s42003-0…

Astrocyte Pharmaceuticals avatar
⟳ Kenneth Jacobson retweeted
Astrocyte Pharmaceuticals@AstrocytePharma·20 Aug 2025

Footy star reveals concussion toll: 'I haven't slept unaided in years' mol.im/a/14752339 via @MailSport Astrocyte's new #STARFAST clinical trial is now treating concussed players in the Adelaide Footy League with AST-004 to see if we can limit these debilitating effects.

Kenneth Jacobson avatar
Kenneth Jacobson@KAJacobson·11 Jun 2025

Carolyn Bertozzi delivered an amazing Margaret Pittman lecture today at NIH, & succeeded to explain complicated bioorthogonal chemistry to the broader scientific audience.

Post attachment
Astrocyte Pharmaceuticals avatar
⟳ Kenneth Jacobson retweeted
Astrocyte Pharmaceuticals@AstrocytePharma·16 May 2025

Astrocytes are stepping into the spotlight. 🌟 A trio of new Science papers reveals just how central these cells are to brain function—and why they may be the key to recovery after injury. Huge implications for TBI and stroke. science.org/doi/10.1126/scie…

Astrocyte Pharmaceuticals avatar
⟳ Kenneth Jacobson retweeted
Astrocyte Pharmaceuticals@AstrocytePharma·21 Apr 2025

Summary of Astrocyte's Phase 1A clinical trial of AST-004 featured this month in @StrokeAHA_ASA's Article Commentary. For the Phase 1B study that also showed high safety and tolerability of extending dosing, the manuscript is in preparation - stay tuned! ahajournals.org/do/10.1161/b…

PhysOrgChem@MU avatar
⟳ Kenneth Jacobson retweeted
PhysOrgChem@MU@PhysOrgChem_MU·21 Dec 2024

Beautiful excursion into the history and importance of Photoremovable Protecting Groups: pubs.acs.org/doi/10.1021/jac… One of the best papers I have read this year. Congratulations to authors!

Kenneth Jacobson avatar
Kenneth Jacobson@KAJacobson·17 Apr 2024

Cryo-EM A3 adenosine receptor structures, from SIMM, with both of the potent and selective A3 agonists that are in advanced clinical trials by CanFite. We invented both molecules, and they are widely used in research, as well: IB-MECA and Cl-IB-MECA. doi.org/10.1038/s41467-024-4…